COMBINATION THERAPY OF ISCHEMIC STROKE USING CHOLINE ALFOSCERATE AND ETHYLMETHYLHYDROXYPYRIDINE SUCCINATE


V.I. Shmyrev, S.M. Kryzhanovsky

The article presents the results of study aimed to evaluation of therapeutic effect of the combined 14-day therapy with choline alfoscerate (Cereton 1000 mg/day) and ethylmethylhydroxypyridine succinate (Neurox 250 mg/day) in patients with mild-to-moderate ischemic stroke. Significant positive effect of combination therapy on the recovery of neurologic symptoms at the 30th day of observation was demonstrated. Combination therapy had a less impact on the recovery of daily activity at the 30th day of observation; however, positive trend allows to predict better outcomes against the background of measures in early rehabilitation period.

Similar Articles


Бионика Медиа